Company: DVAX
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001029142-25-000049
Chunk: 51

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-20
Form: 10-K
Item: Item 15
Chunk 51
---
 Paradiso10.110-QMay 2, 2023001-34207

114

Table of Contents

10.7+Amendment No. 1 to Consulting Agreement and Statement of Work No. 1, effective January 16, 2025, between Company and Peter ParadisoX10.8+Form of Indemnification Agreement10.110-QNovember 7, 2019001-3420710.9+Form of Management Continuity and Severance Agreement between Company and certain of its executive officers10.310-QAugust 3, 2023001-3420710.10+Dynavax Technologies Corporation Annual Bonus Plan10.210-QAugust 6, 2024001-3420710.11+Non-Employee Director Compensation PolicyX10.12Sales Agreement, dated August 6, 2020, between Company and Cowen and Company, LLC10.310-QAugust 6, 2020001-3420710.13Amendment No. 1 to Sales Agreement with Cowen and Company, LLC1.3S-3 ASRAugust 3, 2023333-27367410.14Form of Confirmation for Capped Call Transactions10.18-KMay 13, 2021001-3420710.15+Dynavax Technologies Corporation Amended and Restated 2014 Employee Stock Purchase PlanAppendix ADEF 14AApril 16, 2021001-3420710.16+Dynavax Technologies Corporation 2018 Equity Incentive Plan10.110-QAugust 6, 2024001-3420710.17+Form of Option Grant Notice and Option Agreement under the 2018 Equity Incentive Plan10.38-KJune 1, 2018001-3420710.18+Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2018 Equity Incentive Plan10.28-KJune 1, 2018001-3420710.19+Restricted Stock Unit Award Agreement for Directors under the 2018 Equity Incentive Plan10.1110-KFebruary 28, 2022001-3420710.20+Amended and Restated Dynavax Technologies Corporation 2021 Inducement Award Plan10.310-QAugust 4, 2021001-3420710.21•Office/Laboratory Lease, dated September 17, 2018, between Company and Emery